| Identification | Back Directory | [Name]
CBP501 AffinityPeptide | [CAS]
1351804-17-5 | [Synonyms]
CBP501 AffinityPeptide
L-Glutamic acid, L-asparaginyl-L-seryl-L-α-aspartyl-L-cysteinyl-L-isoleucyl-L-isoleucyl-L-seryl-L-arginyl-L-lysyl-L-isoleucyl-L-α-glutamyl-L-glutaminyl-L-lysyl- | [Molecular Formula]
C68H119N21O25S | [MOL File]
1351804-17-5.mol | [Molecular Weight]
1662.88 |
| Hazard Information | Back Directory | [Uses]
CBP501 Affinity Peptide is a Chk kinase inhibitor that can abrogate G2 arrest induced by DNA-damaging agents. CBP501 Affinity Peptide can be used in cancer research[1]. | [References]
[1] Matsumoto Y, et al. Screening of a library of T7 phage-displayed peptides identifies alphaC helix in 14-3-3 protein as a CBP501-binding site. Bioorg Med Chem. 2011 Dec 1;19(23):7049-56. DOI:10.1016/j.bmc.2011.10.004 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|